Bio-Rad Laboratories (BIO-N) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr03/2026	Next Qtr06/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$2.77	$2.34	$10.32	$9.30
Number of Estimates	1	1	1	1
High Estimate	$2.77	$2.34	$10.32	$9.30
Low Estimate	$2.77	$2.34	$10.32	$9.30
Prior Year	$2.54	$2.61	$9.92	$10.32
Growth Rate Est. (year over year)	+9.06%	-10.34%	+4.03%	-9.88%

Earnings History - Surprises*

	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025	Qtr Ending03/2025
Reported	$2.51	$2.26	$2.61	$2.54
Estimate	$2.57	$2.30	$1.93	$1.73
Difference	-0.06	-0.04	+0.68	+0.81
Surprise	-2.33%	-1.74%	+35.23%	+46.82%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

3.80

3 Mths Ago5

3.80

2 Mths Ago5

3.50

1 Mth Ago4

3.00

Current4

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	5	5	4	4
	2	2	1
Holds	3	3	3	4

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Lululemon appoints long-time Nike executive Heidi O’Neill as new CEO

Bullish on Pembina Pipeline Corp.

How investors should digest the stock market’s ‘sugar high’

Market Factors: Top picks, sector review for income-heavy utilities sector

The most oversold and overbought stocks on the TSX

The highest-yielding stocks on the TSX, plus risk data

Barlow’s Research Roundup: These stocks are biggest winners from oil price volatility

It’s not just Allbirds - another meme-stock season is on the horizon, Vanda Research says